PCC Statement on the Opening of the Phase II Review:
Proposed Acquisition by GlaxoSmithKline Consumer Healthcare Holdings, Ltd. (GSK)
of Pfizer Inc.’s Global Consumer Healthcare Business (Pfizer)
M-2019-005
PCC Statement on the Opening of the Phase II Review:
Proposed Acquisition by GlaxoSmithKline Consumer Healthcare Holdings, Ltd. (GSK)
of Pfizer Inc.’s Global Consumer Healthcare Business (Pfizer)
M-2019-005